- Home
- IMMP vs NNOX Comparison
IMMP vs NNOX Comparison
Compare IMMP & NNOX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- NNOX
- Stock Information
- Founded
- IMMP 1987
- NNOX 2011
- Country
- IMMP Australia
- NNOX Israel
- Employees
- IMMP N/A
- NNOX N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- NNOX Medical Electronics
- Sector
- IMMP Health Care
- NNOX Health Care
- Exchange
- IMMP Nasdaq
- NNOX Nasdaq
- Market Cap
- IMMP 251.8M
- NNOX 253.8M
- IPO Year
- IMMP N/A
- NNOX 2020
- Fundamental
- Price
- IMMP $1.93
- NNOX $3.70
- Analyst Decision
- IMMP Buy
- NNOX Strong Buy
- Analyst Count
- IMMP 1
- NNOX 2
- Target Price
- IMMP $7.00
- NNOX $8.50
- AVG Volume (30 Days)
- IMMP 208.1K
- NNOX 1.3M
- Earning Date
- IMMP 10-10-2025
- NNOX 11-20-2025
- Dividend Yield
- IMMP N/A
- NNOX N/A
- EPS Growth
- IMMP N/A
- NNOX N/A
- EPS
- IMMP N/A
- NNOX N/A
- Revenue
- IMMP $3,306,742.00
- NNOX $11,886,000.00
- Revenue This Year
- IMMP $16.82
- NNOX $20.50
- Revenue Next Year
- IMMP N/A
- NNOX $64.10
- P/E Ratio
- IMMP N/A
- NNOX N/A
- Revenue Growth
- IMMP 31.28
- NNOX 17.36
- 52 Week Low
- IMMP $1.32
- NNOX $3.60
- 52 Week High
- IMMP $2.71
- NNOX $11.00
- Technical
- Relative Strength Index (RSI)
- IMMP 45.60
- NNOX 41.01
- Support Level
- IMMP $1.88
- NNOX $3.63
- Resistance Level
- IMMP $2.08
- NNOX $4.17
- Average True Range (ATR)
- IMMP 0.10
- NNOX 0.20
- MACD
- IMMP -0.03
- NNOX -0.05
- Stochastic Oscillator
- IMMP 4.97
- NNOX 7.56
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About NNOX NANO-X IMAGING LTD
Nano X Imaging Ltd is engaged in the business of manufacturing medical imaging systems. It offers a Nanox System which is a combination of hardware and software. It develops a prototype of the Nanox.ARC, a medical imaging system incorporating its novel digital X-ray source; and Nanox.CLOUD, a companion cloud-based software that will allow for the delivery of medical screening as a service. It has three business segments: Nanox.ARC division, the radiology services division and the AI solutions division. Key revenue is generated from Radiology Services.